The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized 'anti-TNF' therapies.

Current directions in autoimmunity

Volumn 5, Issue , 2002, Pages 30-50

  Kollias, George ^a   Kontoyiannis, Dimitris ^a   Douni, Eleni ^a   Kassiotis, George ^a  

^a BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ANIMAL MODEL; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHEMISTRY; CLASSIFICATION; DRUG ANTAGONISM; DRUG DESIGN; GENETIC PREDISPOSITION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PHYSIOLOGY; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

AMINO ACID MOTIFS; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DRUG DESIGN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MODELS, ANIMAL; ORGAN SPECIFICITY; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036356811     PISSN: 14222132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)